Mohamed Abouelkhair, DVM, MS, PhD, DACVM (Immun&Viro), C-ABMM
Specialization: Diplomate American College of Veterinary Microbiologists: Virology and Immunology
My academic research spans multiple focal areas, including microbial genomics, the development of molecular assays like CRISPR for detecting infectious diseases, cancer research focusing on the tumor microenvironment, and viral immunology. Dr. Abouelkhair's work has led to significant findings, including identifying antimicrobial resistance distribution in Animal staphylococcal pathogen across U.S., Africa, and Europe and uncovering molecular determinants responsible for immune evasion and pathogenicity, which could inform vaccine development. Notably, Dr. Abouelkhair holds a U.S. patent for "Staphylococcus pseudintermedius virulence factor vaccine compositions," showcasing notable contributions to the field. Another branch of Dr. Abouelkhair's research focuses on studying the tumor microenvironment and exploring the clinical applications of Natural Killer (NK) cells and Chimeric Antigen Receptor (CAR) NK cells as potential cancer immunotherapies in animals.
Microbial Bioinformatics, development of new molecular assays (including CRISPR) for detection of existing and emerging infectious diseases and Cancer and Viral Immunology.
Clinical immunology; Clinical Virology; Flow cytometry-based cell analysis; Modulation of the immune response.
Graduate and veterinary student training in Molecular Biology, Immunology (VMP813, CEM 541), Virology (VMP821), Microbial Bioinformatics, and Vaccine development
American Veterinary Medical Association: American College of Veterinary Microbiologist, American Association of Immunologists, American Society for Virology, American board of Medical Microbiology, American Society for Microbiology...
2407 River Drive
Knoxville, TN 37996
- Doctorate, Comparative and Experimental Medicine, Univ of Tennessee Knoxville*, 2019
- Masters, Microbiology, University of Sadat City, 2013
- DVM, Veterinary Science, University of Sadat City, 2009
Mohamed Abouelkhair, DVM, MS, PhD, DACVM (Immun&Viro), C-ABMM
2407 River Drive
Knoxville, TN 37996
- Doctorate, Comparative and Experimental Medicine, Univ of Tennessee Knoxville*, 2019
- Masters, Microbiology, University of Sadat City, 2013
- DVM, Veterinary Science, University of Sadat City, 2009
My academic research spans multiple focal areas, including microbial genomics, the development of molecular assays like CRISPR for detecting infectious diseases, cancer research focusing on the tumor microenvironment, and viral immunology. Dr. Abouelkhair's work has led to significant findings, including identifying antimicrobial resistance distribution in Animal staphylococcal pathogen across U.S., Africa, and Europe and uncovering molecular determinants responsible for immune evasion and pathogenicity, which could inform vaccine development. Notably, Dr. Abouelkhair holds a U.S. patent for "Staphylococcus pseudintermedius virulence factor vaccine compositions," showcasing notable contributions to the field. Another branch of Dr. Abouelkhair's research focuses on studying the tumor microenvironment and exploring the clinical applications of Natural Killer (NK) cells and Chimeric Antigen Receptor (CAR) NK cells as potential cancer immunotherapies in animals.
Microbial Bioinformatics, development of new molecular assays (including CRISPR) for detection of existing and emerging infectious diseases and Cancer and Viral Immunology.
Clinical immunology; Clinical Virology; Flow cytometry-based cell analysis; Modulation of the immune response.
Graduate and veterinary student training in Molecular Biology, Immunology (VMP813, CEM 541), Virology (VMP821), Microbial Bioinformatics, and Vaccine development
American Veterinary Medical Association: American College of Veterinary Microbiologist, American Association of Immunologists, American Society for Virology, American board of Medical Microbiology, American Society for Microbiology...